PRFX — PainReform Share Price
0.000.00%
Last trade - 00:00- $2.84m
- -$1.42m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.56 | ||
| Price to Tang. Book | 1.56 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -704.42% | ||
| Return on Equity | -321.92% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 2nd, 2007
- Public Since
- September 1st, 2020
- No. of Shareholders
- 4
- No. of Employees
- 2
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 2,013,141
- Address
- 65 Yigal Alon St., TEL AVIV-YAFO, 6744316
- Web
- https://painreform.com/
- Phone
- +972 37177051
- Auditors
- Kesselman & Kesselman
Upcoming Events for PRFX
Q2 2025 PainReform Ltd Earnings Release
Similar to PRFX
60 Degrees Pharmaceuticals
NASDAQ Capital Market
Abeona Therapeutics
NASDAQ Capital Market
Akari Therapeutics
NASDAQ Capital Market
Akebia Therapeutics
NASDAQ Capital Market
Alpha Cognition
NASDAQ Capital Market
FAQ
What is the PainReform share price?
As of Today at 22:32 UTC, shares in PainReform are trading at $1.41. This share price information is delayed by 15 minutes.
How has the PainReform share price performed this year?
Shares in PainReform last closed at $1.41 and the price had moved by -88.21% over the past 365 days. In terms of relative price strength the PainReform share price has underperformed the S&P500 Index by -89.57% over the past year.
What are the analyst and broker recommendations for PainReform?
The overall consensus recommendation for PainReform is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the PainReform dividend yield?
PainReform does not currently pay a dividend.
Does PainReform pay a dividend?
PainReform does not currently pay a dividend.
When does PainReform next pay dividends?
PainReform does not currently pay a dividend.
How do I buy PainReform shares?
To buy shares in PainReform you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of PainReform?
As of the previous close price of $1.41, shares in PainReform had a market capitalisation of $2.84m.
Where are PainReform shares listed?
Here are the trading details for PainReform:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: PRFX
What kind of share is PainReform?
Based on an overall assessment of its quality, value and momentum PainReform is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a PainReform share price forecast for 2025?
The analyst consensus target price for shares in PainReform is $12.00. That is 751.06% above the last closing price of $1.41.
Analysts covering PainReform currently have a consensus Earnings Per Share (EPS) forecast of -$48.24 for the next financial year.
Find out moreWhat is the trend in the PainReform share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PainReform. Over the past six months, its share price has underperformed the S&P500 Index by -61.45%.
As of the last closing price of $1.41, shares in PainReform were trading -47.73% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the PainReform PE Ratio?
The PainReform PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.41.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of PainReform?
We do not have data on PainReform's directors